This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers at the Cancer Treatment Centers of America present a method that uses quality-of-life assessment as a predictor of survival in patients with non-small-cell lung cancer. The team studied 1,194 lung cancer patients, and found that global quality of life as well as physical function predicted patient survival in the entire study population. "Every 10-point increase in physical function was associated with a 10 percent increase in survival," the authors write.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.